Camber Capital Management LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$11,138
-25.5%
4,235,0000.0%0.37%
-24.6%
Q2 2023$14,950
+14.2%
4,235,0000.0%0.49%
+21.1%
Q1 2023$13,086
-27.0%
4,235,0000.0%0.40%
-34.5%
Q4 2022$17,914
-99.8%
4,235,0000.0%0.61%
+100.0%
Q3 2022$10,037,000
-16.8%
4,235,0000.0%0.31%
-41.4%
Q2 2022$12,070,000
+4.8%
4,235,000
+5.9%
0.52%
+25.7%
Q1 2022$11,520,000
+84.9%
4,000,000
+95.1%
0.42%
+94.9%
Q4 2021$6,232,000
-74.0%
2,050,000
-40.1%
0.21%
-71.0%
Q3 2021$24,009,000
-4.0%
3,425,000
+25.7%
0.74%
-12.3%
Q2 2021$25,016,000
+0.7%
2,725,000
+6.7%
0.84%
-1.1%
Q1 2021$24,835,000
-5.3%
2,555,0000.0%0.85%
-7.4%
Q4 2020$26,214,000
-49.2%
2,555,000
-50.0%
0.92%
-32.4%
Q3 2020$51,560,000
+106.0%
5,110,000
+112.9%
1.36%
-5.0%
Q2 2020$25,032,000
+52.1%
2,400,000
+23.1%
1.43%
+45.7%
Q1 2020$16,458,000
-37.8%
1,950,000
+50.0%
0.98%
-21.7%
Q4 2018$26,455,000
-23.1%
1,300,000
+73.3%
1.26%
-14.7%
Q3 2018$34,388,000
+42.2%
750,000
+15.4%
1.47%
+50.1%
Q1 2017$24,180,000650,0000.98%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders